Replies to post #58934 on NorthWest Biotherapeutics Inc (NWBO)

[koman]

Pretty close Doc. I'm seeking data. This data from this p2 morphed into a phase 3 trial is way over-due by several yrs unnecessarily. Initially it was due to funding but that is no longer the case. The problem- well that's been discussed many times and unfortunately, the science is trumped by the management issues. Soon, the data from this trial may be needless to say as other technology will make it moot. Science has always been first with me but this company management team is unique in a not so good way that I find the NWBO story fascinating. GL